VR Logo

Unrated

IDBI Healthcare Fund - Regular Plan


Equity: Sectoral-Pharma

1 Lakh

Investment Grown to
₹ 1.35 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.44 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends paid by the mutual fund scheme are taxed at the rate of 10% (effectively 11.648%, including surcharge and cess). This is known as Dividend Distribution Tax (DDT). Though the investor does not pay this tax directly, it is deducted from the dividend income before passing on to the investor.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 22.45 0.39 1.09 0.31 11.42 22.34 34.93 -- -- -- --
S&P BSE Healthcare TRI 22.36 0.51 1.20 2.20 16.71 22.30 31.78 -- -- -- --
Equity: Sectoral-Pharma 23.89 0.27 1.11 0.84 13.29 23.53 37.76 -- -- -- --
Rank within category 7 2 4 6 7 6 7 -- -- -- --
Number of funds in category 9 9 9 9 9 9 8 4 3 3 3

As on 08-Jul-2020

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
IDBI Healthcare Fund - Regular Plan
Unrated
Feb-19 34.93 -- -- 2.42 36
Nippon India Pharma Fund
Unrated
Jun-04 36.95 13.28 6.82 2.24 2,992
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 39.15 -- -- 2.24 1,460
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 36.08 4.69 0.40 2.33 1,139
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 44.59 -- -- 2.51 581

Best & Worst Performance

Best (Period) Worst (Period)
Week 21.25 (01-Apr-2020 - 09-Apr-2020) -10.89 (05-Mar-2020 - 12-Mar-2020)
Month 34.24 (23-Mar-2020 - 22-Apr-2020) -19.39 (20-Feb-2020 - 23-Mar-2020)
Quarter 43.01 (23-Mar-2020 - 22-Jun-2020) -12.18 (23-Dec-2019 - 23-Mar-2020)
Year 37.35 (24-Jun-2019 - 23-Jun-2020) -7.88 (22-Mar-2019 - 23-Mar-2020)

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 7.72 22.96 0.11 0.24 -- --
Equity: Sectoral-Pharma* 10.16 20.10 0.24 0.51 0.85 2.81
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 30-Jun-2020

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 26
Top 10 Stocks (%) 67.36
Top 5 Stocks (%) 46.71
Top 3 Sectors (%) 96.49
Portfolio P/B Ratio 4.28
Portfolio P/E Ratio 32.33

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 37,594 29,284
Giant (%) 13.14 11.15
Large (%) 52.35 50.23
Mid (%) 31.53 23.97
Small (%) 2.98 14.65
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Sun Pharmaceutical Inds. Healthcare 30.84 12.79 0.00 12.79
up Dr. Reddy's Lab Healthcare 31.89 11.67 0.00 11.56
up Divi's Laboratories Healthcare 41.74 10.41 0.00 9.50
up Cipla Healthcare 33.08 7.64 0.00 7.36
up Lupin Healthcare -- 6.19 0.00 5.50
up Ipca Laboratories Healthcare 34.12 6.88 0.00 5.09
up Aurobindo Pharma Healthcare 16.60 5.97 0.00 4.66
up Sanofi India Healthcare 42.56 5.59 0.00 3.73
up Alembic Pharmaceuticals Healthcare 21.17 3.71 0.00 3.71
up Abbott India Healthcare 56.03 4.21 0.00 3.46
up Torrent Pharmaceuticals Healthcare 38.68 3.69 0.00 3.35
up Pfizer Healthcare 36.74 4.05 0.00 2.87
up Apollo Hospitals Healthcare 42.66 4.15 0.00 2.70
up Alkem Laboratories Healthcare 25.76 4.43 0.00 2.57
up Dr. Lal Pathlabs Healthcare 64.95 4.13 0.00 2.57
up Natco Pharma Healthcare 27.05 4.08 0.00 2.47
up Cadila Healthcare Healthcare 31.28 2.30 0.00 2.25
up Aarti Industries Chemicals 30.56 2.30 0.00 1.94
up ICICI Lombard General Insurance Company Financial 49.03 2.16 0.00 1.80
up JB Chemicals & Pharma Healthcare 20.25 1.74 0.00 1.74
up Biocon Healthcare 64.39 2.37 0.00 1.51
up Ajanta Pharma Healthcare 26.55 1.30 0.00 1.30
new Laurus Labs Healthcare 23.21 1.16 0.00 1.16
new Astrazeneca Pharma India Healthcare 119.94 2.00 0.00 0.88
up P&G Hygiene & Health Care FMCG 83.87 1.15 0.00 0.84

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-May-2020

Fund Manager

— Uma Venkatraman since 08-Feb-2019

Education: Prior to joining IDBI Mutual Fund, she had worked with B&K Securities, ASK Raymond James, Morgan Keegan and UTI Mutual Fund.

Funds Managed:


0.39%

Change from previous, NAV as on 08-Jul-2020

Growth: ₹ 12.9800

Dividend: ₹ 12.9800


Investment Strategy

The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 1,000
Minimum Balance (₹) 1
Exit Load 1% for redemption within 365 days

Basic Details

Fund House: IDBI Mutual Fund
Launch Date: 28-Feb-2019
Return Since Launch: 21.16%
Benchmark: S&P BSE Healthcare TRI
Riskometer: High
Type: Open-ended
Assets: ₹ 36 Cr (As on 31-May-2020)
Expense: 2.42% (As on 31-May-2020)
Risk Grade: --
Return Grade: --
Turnover: 60.00%

Contact Information

AMC: IDBI Asset Management Ltd.

Address: 4th Floor, IDBI Tower, WTC Complex, Cuffe Parade, Colaba, Mumbai - 400005

Phone: 022-66442800 / 1800-419-4324

Fax: 022-66442801

Email: [email protected]

Website: http://www.idbimutual.co.in

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

VR Helpline

Investing rationally when markets are irrational.

dateSaturday, 11-Jul-2020
time04:00 PM - 04:30 PM